Circulating intact parathyroid hormone is suppressed at 25-hydroxyvitamin D concentrations > 25 nmol/L in children

Journal of Pediatric Endocrinology and Metabolism

Volumn 27, Issue 7-8, 2014, Pages 657-660

  Crews, Bridgit O ^a   Moore, Jennifer ^b   Dietzen, Dennis J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Calcium; Parathyroid hormone; Renal failure; Rickets; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CREATININE; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; CHILD; CLINICAL INDICATOR; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; HOSPITALIZED CHILD; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PARATHYROID HORMONE BLOOD LEVEL; PEDIATRIC HOSPITAL; SCHOOL CHILD; TERTIARY HEALTH CARE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; FEMALE; MALE; PRESCHOOL CHILD; REFERENCE VALUE; YOUNG ADULT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PARATHYROID HORMONE; REFERENCE VALUES; VITAMIN D; YOUNG ADULT;

EID: 84907164826     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2014-0012     Document Type: Article

References (22)

1. Holick MF. Vitamin D for health and chronic kidney disease. Sem Dial 2005;18:266-75
2. Durazo-Arvizu RA, Dawson-Hughes B, Sempos CT, Yetley EA, Looker AC, et al. Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. J Nutr 2010;140:595-9
3. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and association of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics 2009;124:e362-70
4. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, et al. Vitamin D status: United States, 2001- 2006. National Center for Health Services Data Brief No. 59; 2011
5. Centers for Disease Control and Prevention. Severe malnutrition among young children: Georgia, January 1997-January 1999. MMWR Morb Mortal Wkly Rep 2001;50:224-7
6. Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 2009;160:491-7
7. Wagner CL, Greer FR, and the Section on Breastfeeding and Committee on Nutrition. Prevention of rickets and vitamin d deficiency in infants, children, and adolescents. Pediatrics 2008;122:1142-52
8. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press; 2011
9. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine soci ety clinical practice guideline. J Clin Endocrin Metab 2011;96:1-29
10. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90:3215-24
11. Abrams SA, Griffin IJ, Hawthorne KM, Gunn SK, Gundberg CM, et al. Relationships among vit amin D levels, parathyroid hormone, and calcium absorption in young adolescents. J Clin Endocrinol Metab 2005;90:5576-81
12. Hill KM, McCabe GP, McCabe LD, Gordon CM, Abrams SA. An inflecti on point of serum 25-hydroxyvitamin D for maximal suppression of parathyroid hormone is not evident from multi-site pooled data in children and adolescents. J Nutr 2010;140:1983-8
13. Srivastava T, Garg U, Ruiz M, Dai H, Alon US. Serum 25(OH)-vitamin D level in children: Is there a need to change the reference range based on the 2011 institute of medicine report? Clin Pediatr 2013;52:178-82
14. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, et al. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 2012;58:531-42
15. Heijboer AC, Blankenstein MA, Kema IP, Buijs MM. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012;58:543-8
16. De nimal D, Ducros V, Dupre T, Dousset B, Meunier C, et al. Agreement of seven 25-hydroxyvitamin D3 immunoassays and three high performance liquid chromatography methods with liquid chromatography mass spectrometry. Clin Chem Lab Med 2013 ; DOI: 10.1515/cclm-2013-0434
17. College of American Pathologists. 2013 Ligand Y-B survey participant summary. Northfield, IL: College of American Pathologists, 2013
18. Faul F, Erdfelde r E, Lang AG, Buchner A. G∗Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Meth 2007; 39:175-91
19. Shaikh A, Berndt T, Kumar T. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators. Pediatr Nephrol 2008;23:1203-10
20. Lewis R. Mineral and bone disorders in chronic kidney disease: new insights into mechanism and management. Ann Clin Biochem 2012;49:432-40
21. Valcour A, Blocki F, Hawkins DM, Sudhaker DR. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J Clin Endocrinol Metab 2012;97:3989-95
22. Atapattu N, Shaw N, H ögler W. Relationship between serum 25-hydroxyvitamin D and parathyroid hormone in the search or a biochemical definition of vitam in D deficiency in children. Pediatr Res 2013;74:552-6